Overview Fundamentals API Earnings EOD API Sample Code Pricing

QUALIGEN THER.NEW DL-001 (7R9 F) stock market data APIs

€0.188 0(0%) as of July 26, 2024
Price chart is built with Anychart

Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

QUALIGEN THER.NEW DL-001 Financial Data Overview

0.188
0.188
-
0.188
0.188
0.102-1.066
2 826 K
11 383 K
4 984 K
0.082
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '7R9',
Type: 'Common Stock',
Name: 'QUALIGEN THER.NEW DL-001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

QUALIGEN THER.NEW DL-001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 984 K
  • EBITDA -10 128 838
  • Earnings Per Share -1.99
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get QUALIGEN THER.NEW DL-001 Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get QUALIGEN THER.NEW DL-001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com